— Know what they know.
Not Investment Advice

MBCI OTC

MabCure Inc.
1W: +0.0% 1M: -80.0% 3M: -93.3% YTD: -80.0% 1Y: -80.0% 3Y: -99.6% 5Y: -98.9%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 47 · $1464 mcap · 32M float · 0.0031% daily turnover · Short 57% of daily vol

Income Trends

Revenue
$500K +0.0% ▲
Gross Profit
$500K +0.0% ▲
Operating Income
-$710K +30.4% ▲
Net Income
-$12M -769.1% ▼
EPS (Diluted)
$-0.20 -765.8% ▼
EBITDA
-$12M -1134.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2007FY2008FY2009FY2010FY2011
Revenue$0$0$0$0$500K
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$0$0$0
Gross Profit$0$0$0$0$500K
Gross Margin————100.0%
R&D Expenses$0$4K$403K$352K$391K
SG&A Expenses$106K$528K$940K$667K$819K
Operating Expenses$106K$536K$1M$1M$1M
Operating Income-$106K-$536K-$1M-$1M-$710K
Operating Margin————-141.9%
Interest Expense$0$970$17K$207K$187K
Income Before Tax$0-$531K-$1M-$1M-$12M
Tax Expense$106K$970$17K$207K$187K
Net Income-$106K-$531K-$1M-$1M-$12M
Net Margin————-2490.3%
EPS (Diluted)$-0.00$-0.01$-0.02$-0.02$-0.20
EBITDA-$106K-$526K-$1M-$976K-$12M
Shares Outstanding50M43M60M62M64M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms